Westerkirk Capital Inc. Edwards Lifesciences Corp Transaction History
Westerkirk Capital Inc.
- $875 Billion
- Q3 2025
A detailed history of Westerkirk Capital Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Westerkirk Capital Inc. holds 5,700 shares of EW stock, worth $491,910. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,700
Previous 6,300
9.52%
Holding current value
$491,910
Previous $493 Million
10.03%
% of portfolio
0.05%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding EW
# of Institutions
1,461Shares Held
468MCall Options Held
3.46MPut Options Held
4.07M-
Vanguard Group Inc Valley Forge, PA70.4MShares$6.07 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...